{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:38:19Z","timestamp":1792723099789,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","revespcardiol.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.rec.2026.09.001","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:08:12Z","timestamp":1790780892000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Percutaneous left atrial appendage occlusion versus oral anticoagulation in patients with atrial fibrillation: a systematic review and meta-analysis"],"prefix":"10.1016","author":[{"given":"Maddalena Immobile","family":"Molaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cajetan","family":"Reichardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorenzo","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doruntina","family":"Lahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gjin","family":"Ndrepepa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costanza","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"von Scheidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Rheude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Voll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor Alfonso \u00c1lvarez","family":"Covarrubias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Trenkwalder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik B.","family":"Sager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heribert","family":"Schunkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Joner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Kastrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cassese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erion","family":"Xhepa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2026.09.001_bib0150","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2026.09.001_bib0155","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke."},{"key":"10.1016\/j.rec.2026.09.001_bib0160","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/eurheartj\/ehr393","article-title":"Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation","volume":"33","author":"Landmesser","year":"2012","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2026.09.001_bib0165","first-page":"4349","article-title":"Endorsed by the European Stroke Organisation (ESO)","volume":"46","year":"2025","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2026.09.001_bib0170","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2026.09.001_bib0175","first-page":"2914","article-title":"Left atrial appendage closure for stroke prevention in atrial fibrillation: current status and perspectives","volume":"45","author":"Landmesser","year":"2024","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2026.09.001_bib0180","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa2517213","article-title":"Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation","volume":"394","author":"Doshi","year":"2026","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2026.09.001_bib0185","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJMoa2513310","article-title":"Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation","volume":"394","author":"Landmesser","year":"2026","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2026.09.001_bib0190","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa2408308","article-title":"Left Atrial Appendage Closure after Ablation for Atrial Fibrillation","volume":"392","author":"Wazni","year":"2025","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2026.09.001_bib0195","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2026.09.001_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2026.09.001_bib0205","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA."},{"key":"10.1016\/j.rec.2026.09.001_bib0210","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/CIRCULATIONAHA.123.067312","article-title":"Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients With Atrial Fibrillation","volume":"149","author":"Kapadia","year":"2024","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2026.09.001_bib0215","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Writing Committee","year":"2024","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2026.09.001_bib0220","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ."},{"key":"10.1016\/j.rec.2026.09.001_bib0225","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.rec.2026.09.001_bib0230","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet."},{"key":"10.1016\/j.rec.2026.09.001_bib0235","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2026.09.001_bib0240","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2026.09.001_bib0245","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.027001","article-title":"Percutaneous Left Atrial Appendage Occlusion in Comparison to Non-Vitamin K Antagonist Oral Anticoagulant Among Patients With Atrial Fibrillation","volume":"11","author":"Noseworthy","year":"2022","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.rec.2026.09.001_bib0250","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2026.09.001_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation","volume":"79","author":"Osmancik","year":"2022","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2026.09.001_bib0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacep.2026.06.033","article-title":"Left Atrial Appendage Closure vs Anticoagulation for Stroke Prevention in Atrial Fibrillation: Meta-Analysis of Randomized Trials","author":"Turagam","year":"2026","journal-title":"JACC Clin Electrophysiol."},{"key":"10.1016\/j.rec.2026.09.001_bib0265","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jcin.2015.08.035","article-title":"Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled Patient-Level Analysis of the WATCHMAN Randomized Trial Experience","volume":"8","author":"Price","year":"2015","journal-title":"JACC Cardiovasc Interv."},{"key":"10.1016\/j.rec.2026.09.001_bib0270","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/ehjcvp\/pvaf078","article-title":"Antithrombotic strategies and DOAC dosing following left atrial appendage occlusion: a network meta-analysis","volume":"12","author":"Samaras","year":"2026","journal-title":"Eur Heart J Cardiovasc Pharmacother."},{"key":"10.1016\/j.rec.2026.09.001_bib0275","first-page":"e1947","article-title":"Direct Oral Anticoagulant Monotherapy Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure: A Meta-Analysis of Randomized Trials","volume":"23","author":"Ammirabile","year":"2026","journal-title":"Circ Cardiovasc Interv."},{"key":"10.1016\/j.rec.2026.09.001_bib0280","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1161\/CIRCULATIONAHA.125.077469","article-title":"Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure: The ANDES Randomized Clinical Trial","volume":"152","author":"Rodes-Cabau","year":"2025","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2026.09.001_bib0285","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jamacardio.2024.2335","article-title":"Low-Dose Direct Oral Anticoagulation vs Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion: The ADALA Randomized Clinical Trial","volume":"9","author":"Freixa","year":"2024","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.rec.2026.09.001_bib0290","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.recesp.2025.11.015","article-title":"Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: 1-year results from the ADALA trial","volume":"79","author":"Flores-Umanzor","year":"2026","journal-title":"Rev Esp Cardiol."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585726002136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585726002136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:54:52Z","timestamp":1792720492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585726002136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"alternative-id":["S1885585726002136"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2026.09.001","relation":{},"ISSN":["1885-5857"],"issn-type":[{"value":"1885-5857","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Percutaneous left atrial appendage occlusion versus oral anticoagulation in patients with atrial fibrillation: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2026.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}